Number of human embryonic and fetal tissues used in this study and respective type of analysis effectuated
| Age . | . | . | . |
|---|---|---|---|
| Embryo, Carnegie stage | Days | IHC analysis | In vitro analysis |
| 8-9 | 19-21 | 2 | ND |
| 10 | 22-23 | 7 | 3 |
| 11 | 24-25 | 5 | 3 |
| 12 | 26-27 | 9 | 4 |
| 13 | 28-30 | 2 | ND |
| 14 | 31-32 | 2 | ND |
| 15 | 33-36 | 4 | ND |
| 16 | 37-40 | 2 | ND |
| 17 | 41-43 | 1 | ND |
| Liver, wk | IHC analysis | In vitro analysis | In vivo analysis |
| 4-6 | 15 | ND | ND |
| 7-11 | 8 | 7 | ND |
| 14-20 | 3 | 5 | 7 |
| 21-27 | 3 | 2 | ND |
| BM, wk | FACS analysis | In vitro analysis | In vivo analysis |
| 7-11 | 2 | ND | ND |
| 14-20 | 3 | 3 | 2 |
| 21-22 | ND | 2 | 1 |
| Age . | . | . | . |
|---|---|---|---|
| Embryo, Carnegie stage | Days | IHC analysis | In vitro analysis |
| 8-9 | 19-21 | 2 | ND |
| 10 | 22-23 | 7 | 3 |
| 11 | 24-25 | 5 | 3 |
| 12 | 26-27 | 9 | 4 |
| 13 | 28-30 | 2 | ND |
| 14 | 31-32 | 2 | ND |
| 15 | 33-36 | 4 | ND |
| 16 | 37-40 | 2 | ND |
| 17 | 41-43 | 1 | ND |
| Liver, wk | IHC analysis | In vitro analysis | In vivo analysis |
| 4-6 | 15 | ND | ND |
| 7-11 | 8 | 7 | ND |
| 14-20 | 3 | 5 | 7 |
| 21-27 | 3 | 2 | ND |
| BM, wk | FACS analysis | In vitro analysis | In vivo analysis |
| 7-11 | 2 | ND | ND |
| 14-20 | 3 | 3 | 2 |
| 21-22 | ND | 2 | 1 |
IHC indicates immunohistochemistry; and ND, not done.